Geode Capital Management
ICCM icon

Geode Capital Management’s IceCure Medical ICCM Stock Holding History

Geode Capital Management’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,348
Closed -$12.2K – 4511
2026
Q1 		$12.2K Hold
1,348
– – ﹤0.01% 4482
2025
Q4 		$24.7K Hold
1,348
– – ﹤0.01% 4358
2025
Q3 		$41.3K Hold
1,348
– – ﹤0.01% 4331
2025
Q2 		$40.3K Hold
1,348
– – ﹤0.01% 4257
2025
Q1 		$48.1K Hold
1,348
– – ﹤0.01% 4210
2024
Q4 		$44.5K Buy
1,348
+496
+58% +$11.4K ﹤0.01% 4262
2024
Q3 		$15.6K Hold
852
– – ﹤0.01% 4424
2024
Q2 		$18.9K Hold
852
– – ﹤0.01% 4463
2024
Q1 		$30.7K Buy
+852
New +$33.3K ﹤0.01% 4409

Other funds holding ICCM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCM
Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $391M AUM 21.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Geode Capital Management's ICCM Position: Q2 2026 in Review

Geode Capital Management sold out of IceCure Medical (ICCM) in Q2 2026, closing a stake of 1,348 shares — an estimated $12.2K sold.

Geode Capital Management first reported a position in ICCM in Q1 2024 and held it in 9 quarters. The position peaked at $48.1K in Q1 2025. 11 funds tracked by Wall St. Rank hold ICCM as of Q2 2026.

  • Geode Capital Management reported no remaining IceCure Medical position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 1,348 IceCure Medical shares in Q2 2026, an estimated $12.2K.
  • Geode Capital Management first reported a position in IceCure Medical in Q1 2024 and held it in 9 quarters.
  • Geode Capital Management's IceCure Medical position peaked at $48.1K in Q1 2025.
  • 11 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.